Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2009 Jun;94(6):887-8.
doi: 10.3324/haematol.2009.005561.

Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages

Massimo Gentile, Giovanna Cutrona, Antonino Neri, Stefano Molica, Manlio Ferrarini, Fortunato Morabito
Comment

Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages

Massimo Gentile et al. Haematologica. 2009 Jun.
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
(A) Kaplan–Meier estimates of treatment-free survival (TFS). Comparison between β2-mneg patients versus β2-mpos patients. (B) Cox univariate analysis for the predictive value of marker combinations for the risk categories. (C) Cox derived estimated TTT curves according to the combination of the three prognostic factors.
See this image and copyright information in PMC

Comment on

References

    1. Rossi D, Zucchetto A, Rossi FM, Capello D, Cerri M, Deambrogi C, et al. CD49d expression is an independent risk factor of progressive disease in early stage chronic lymphocytic leukemia. Haematologica. 2008;93:1575–9. - PubMed
    1. Simonsson B, Wibell L, Nilsson K. β2-microglobulin in chronic lymphocytic leukaemia. Scand J Haematol. 1980;24:174–80. - PubMed
    1. Gentile M, Mauro FR, Guarini A, Foà R. New developments in the diagnosis, prognosis and treatment of chronic lymphocytic leukemia. Curr Opin Oncol. 2005;17:597–604. - PubMed
    1. Keating MJ, Lerner S, Kantarjian H, Freireich EJ, O'Brien S. The serum β2-microglobulin (β2m) level is more powerful than stage in predicting response and survival in chronic lymphocytic leukemia (CLL) Blood. 1995;86 (Suppl 1):606a. [Abstract]
    1. Wierda WG, O’Brien S, Wang X, Faderl S, Ferrajoli A, Do KA, et al. Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia. Blood. 2007;109:4679–85. - PubMed